Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-04 06:07 am Sale | 2023-04-27 | 13D | Chembio Diagnostics, Inc. CEMI | PERCEPTIVE ADVISORS LLC | 0 0.000% | -4,919,334 (Position Closed) | Filing History |
| 2023-05-01 09:21 am Purchase | 2023-04-27 | 13D | Chembio Diagnostics, Inc. CEMI | Biosynex SA | 37,059,993 100.000% | 37,059,993 (New Position) | Filing History |
| 2023-04-21 5:36 pm Purchase | 2023-04-19 | 13D | Chembio Diagnostics, Inc. CEMI | PERCEPTIVE ADVISORS LLC | 4,919,334 13.400% | 494,234 (+11.17%) | Filing History |
| 2023-04-07 5:19 pm Purchase | 2023-03-30 | 13D | Chembio Diagnostics, Inc. CEMI | PERCEPTIVE ADVISORS LLC | 4,425,100 12.000% | 4,425,100 (New Position) | Filing History |
| 2022-02-09 3:33 pm Purchase | 2021-12-31 | 13G | Chembio Diagnostics, Inc. CEMI | VANGUARD GROUP INC | 1,405,785 4.680% | 367,502 (+35.40%) | Filing History |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | Chembio Diagnostics, Inc. CEMI | BlackRock Inc. BLK | 199,249 1.000% | -1,000,345 (-83.39%) | Filing History |
| 2021-02-16 12:24 pm Sale | 2020-12-31 | 13G | Chembio Diagnostics, Inc. CEMI | LYTTON LAURENCE W | 0 0.000% | -1,010,718 (Position Closed) | Filing History |
| 2021-02-12 06:42 am Sale | 2020-12-31 | 13G | Chembio Diagnostics, Inc. CEMI | Nantahala Capital Management LLC | 0 0.000% | -1,239,983 (Position Closed) | Filing History |
| 2021-02-10 10:46 am Purchase | 2020-12-31 | 13G | Chembio Diagnostics, Inc. CEMI | VANGUARD GROUP INC | 1,038,283 5.150% | 1,038,283 (New Position) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Chembio Diagnostics, Inc. CEMI | BlackRock Inc. BLK | 1,199,594 5.900% | 1,199,594 (New Position) | Filing History |
| 2021-01-29 10:29 am Sale | 2020-12-31 | 13G | Chembio Diagnostics, Inc. CEMI | ROYCE & ASSOCIATES LP | 491,453 2.440% | -500,039 (-50.43%) | Filing History |